142 related articles for article (PubMed ID: 33138872)
21. Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): study protocol for a randomised controlled trial.
Kendrick T; Moore M; Leydon G; Stuart B; Geraghty AWA; Yao G; Lewis G; Griffiths G; May C; Dewar-Haggart R; Williams S; Zhu S; Dowrick C
Trials; 2020 May; 21(1):441. PubMed ID: 32471492
[TBL] [Abstract][Full Text] [Related]
22. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
23. Equations for converting scores between depression scales (MÅDRS, SRS, PHQ-9 and BDI-II): good statistical, but weak idiographic, validity.
Hawley CJ; Gale TM; Smith PS; Jain S; Farag A; Kondan R; Avent C; Graham J
Hum Psychopharmacol; 2013 Nov; 28(6):544-51. PubMed ID: 24519690
[TBL] [Abstract][Full Text] [Related]
24. Reliability and validity of the Beck Depression Inventory-Fast Screen for medical patients in the general German population.
Kliem S; Mößle T; Zenger M; Brähler E
J Affect Disord; 2014 Mar; 156():236-9. PubMed ID: 24480380
[TBL] [Abstract][Full Text] [Related]
25. Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety.
Blumenfeld AM; Tepper SJ; Robbins LD; Manack Adams A; Buse DC; Orejudos A; D Silberstein S
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):353-360. PubMed ID: 30630956
[TBL] [Abstract][Full Text] [Related]
26. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.
Richards DA; Bower P; Chew-Graham C; Gask L; Lovell K; Cape J; Pilling S; Araya R; Kessler D; Barkham M; Bland JM; Gilbody S; Green C; Lewis G; Manning C; Kontopantelis E; Hill JJ; Hughes-Morley A; Russell A
Health Technol Assess; 2016 Feb; 20(14):1-192. PubMed ID: 26910256
[TBL] [Abstract][Full Text] [Related]
27. The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach.
Duru G; Fantino B
Curr Med Res Opin; 2008 May; 24(5):1329-35. PubMed ID: 18377706
[TBL] [Abstract][Full Text] [Related]
28. Effect of Collaborative Care vs Usual Care on Depressive Symptoms in Older Adults With Subthreshold Depression: The CASPER Randomized Clinical Trial.
Gilbody S; Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Meer S; Mitchell N; Overend K; Pasterfield M; Pervin J; Richards DA; Spilsbury K; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; McMillan D
JAMA; 2017 Feb; 317(7):728-737. PubMed ID: 28241357
[TBL] [Abstract][Full Text] [Related]
29. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample.
Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM
Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449
[TBL] [Abstract][Full Text] [Related]
30. Self-Directed Engagement with a Mobile App (Sinasprite) and Its Effects on Confidence in Coping Skills, Depression, and Anxiety: Retrospective Longitudinal Study.
Silva Almodovar A; Surve S; Axon DR; Cooper D; Nahata MC
JMIR Mhealth Uhealth; 2018 Mar; 6(3):e64. PubMed ID: 29549066
[TBL] [Abstract][Full Text] [Related]
31. Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold.
Butcher E; Packham C; Williams M; Miksza J; Kaul A; Khunti K; Morriss R
BMC Psychiatry; 2021 Sep; 21(1):446. PubMed ID: 34496806
[TBL] [Abstract][Full Text] [Related]
32. Text Messaging as a Screening Tool for Depression and Related Conditions in Underserved, Predominantly Minority Safety Net Primary Care Patients: Validity Study.
Jin H; Wu S
J Med Internet Res; 2020 Mar; 22(3):e17282. PubMed ID: 32213473
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Outcomes of a Therapist-Supported, Smartphone-Based Intervention for Elevated Symptoms of Depression and Anxiety: Quasiexperimental, Pre-Postintervention Study.
Economides M; Ranta K; Nazander A; Hilgert O; Goldin PR; Raevuori A; Forman-Hoffman V
JMIR Mhealth Uhealth; 2019 Aug; 7(8):e14284. PubMed ID: 31452521
[TBL] [Abstract][Full Text] [Related]
34. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
35. Screening for psychological distress in neurosurgical brain tumor patients using the Patient Health Questionnaire-2.
Bunevicius A; Deltuva V; Tamasauskas S; Tamasauskas A; Bunevicius R
Psychooncology; 2013 Aug; 22(8):1895-900. PubMed ID: 23233453
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic evaluation of the hospital depression scale (HADS) and the Beck depression inventory II (BDI-II) in adults with congenital heart disease using a structured clinical interview: Impact of depression severity.
Westhoff-Bleck M; Winter L; Aguirre Davila L; Herrmann-Lingen C; Treptau J; Bauersachs J; Bleich S; Kahl KG
Eur J Prev Cardiol; 2020 Mar; 27(4):381-390. PubMed ID: 31349778
[TBL] [Abstract][Full Text] [Related]
37. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.
Frasure-Smith N; Lespérance F
Arch Gen Psychiatry; 2008 Jan; 65(1):62-71. PubMed ID: 18180430
[TBL] [Abstract][Full Text] [Related]
38. Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina.
Urtasun M; Daray FM; Teti GL; Coppolillo F; Herlax G; Saba G; Rubinstein A; Araya R; Irazola V
BMC Psychiatry; 2019 Sep; 19(1):291. PubMed ID: 31533674
[TBL] [Abstract][Full Text] [Related]
39. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study.
Haddad M; Walters P; Phillips R; Tsakok J; Williams P; Mann A; Tylee A
PLoS One; 2013; 8(10):e78493. PubMed ID: 24130903
[TBL] [Abstract][Full Text] [Related]
40. Improvements in Depression Outcomes Following a Digital Cognitive Behavioral Therapy Intervention in a Polychronic Population: Retrospective Study.
Venkatesan A; Forster B; Rao P; Miller M; Scahill M
JMIR Form Res; 2022 Jul; 6(7):e38005. PubMed ID: 35788442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
